Immunophenotypic characteristics of multipotent mesenchymal stromal cells that affect the efficacy of their use in the prevention of acute graft vs host disease

Figure 2 Median fluorescence intensity of multipotent mesenchymal stromal cell markers after treatment with pro-inflammatory cytokines. A: HLA-ABC; B: HLA-DR; C: CD90; D: CD105; E: CD73; F: CD274; G: CD146; H: CD54. The analysis was performed on 38 mesenchymal stromal cell samples. The significance of differences was assessed by the method of multiple comparisons in GraphPad and is indicated in the figure: ^aP < 0.05, ^bP < 0.005, ^cP < 0.0005, ^dP < 0.0001. MSCs: Multipotent mesenchymal stromal cells.